Strategic objectives 

Generation and validation of useful tools for diagnosis and prognosis, stratification and treatment of patients in different pathologies.

Research lines

• Mechanisms of development of renal fibrosis. New biomarkers and therapeutic action targets in chronic renal disease (CRD)
• Precise biomarkers of predisposition to and diagnosis and prognosis of acute renal failure (ARF)
• New therapeutic targets in ARF
• Mechanisms of polarisation of macrophages in nephropathies: potentials new therapeutic approaches in kidney inflammation
• Physiopathological mechanisms in renal vasculitis: validation of new diagnostic tools and of patient stratification
• New prognostic biomarkers in haemodialysis
• miRNAs as new diagnostic and prognostic biomarkers in pancreatic cancer
• New therapeutic action targets in pancreatic cancer: KIF3B
• miRNAs as biomarkers in heart failure and mechanisms of cardiac remodelling
• miRNas as stratification tools and new therapeutic action targets in colorectal cancer